INFLUSPLIT TETRA

This brand name is authorized in Hong Kong

Active ingredients

The drug INFLUSPLIT TETRA contains a combination of these active pharmaceutical ingredients (APIs):

1 A/GuangdongMaonan/SWL1536/2019 (H1N1) pdm09-like virus UNII 93PPF41HH8 - INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) WHOLE

Read about Influenza, inactivated, split virus

2 A/Hong Kong/2671/2019 (H3N2)-like virus UNII I24T8PU2V5 - INFLUENZA A VIRUS A/HONG KONG/2671/2019 (H3N2) WHOLE

Read about Influenza, inactivated, split virus

3 B/Washington/02/2019-like virus UNII Z9INN5K5JD - INFLUENZA B VIRUS B/WASHINGTON/02/2019 WHOLE

Read about Influenza, inactivated, split virus

4 B/Phuket/3073/2013-like virus UNII OB7PUXZOKT - INFLUENZA B VIRUS B/PHUKET/3073/2013 WHOLE

Read about Influenza, inactivated, split virus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BB	Influenza vaccines	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines
Discover more medicines within J07BB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 64982